241 filings
Page 2 of 13
8-K
vduen
24 Oct 16
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:00am
8-K
xi5lyykhem21f5knuz
18 Aug 16
Juniper Pharmaceuticals Reports Results from Phase 2b Clinical Trial of
12:00am
8-K
y3kyvup6t rz5l69oiv
4 Aug 16
Juniper Pharmaceuticals Reports Second Quarter 2016 Financial Results
12:00am
8-K
nrf9v
28 Jul 16
Departure of Directors or Certain Officers
12:00am
8-K
ma27gx0j odc5h3n8a
20 Jul 16
Juniper Pharmaceuticals Appoints Alicia Secor President and Chief Executive Officer
12:00am
8-K
exwzhz56gm7 21e9y3
15 Jun 16
Changes in Registrant's Certifying Accountant
12:00am
8-K
rl2xw
2 Jun 16
Juniper Pharmaceuticals Announces Planned Retirement of CEO Frank Condella
12:00am
8-K
6jrcyp91zi
4 May 16
Juniper Pharmaceuticals Reports First Quarter 2016 Financial Results
12:00am
8-K
08b5iuoeo r2vcn6h
24 Mar 16
Juniper Pharmaceuticals Appoints Mary Ann Gray, Ph.D., to Board of Directors
12:00am
8-K
zoolia84
10 Mar 16
Results of Operations and Financial Condition
12:00am
8-K
3t45uwo 48f
10 Nov 15
Juniper Pharmaceuticals Reports Third Quarter 2015 Financial Results
12:00am
8-K
9io90y
20 Oct 15
Entry into a Material Definitive Agreement
12:00am
8-K
n8mrz5ynb41n1
22 Jul 15
Departure of Directors or Certain Officers
12:00am
8-K
rey339qdk978yo3 ng
10 Jul 15
Departure of Directors or Certain Officers
12:00am
8-K
nspwo
28 May 15
Juniper Pharmaceuticals Appoints James A. Geraghty to Board of Directors
12:00am
8-K
ycyub 3thrndsddmvsj
6 May 15
Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results
12:00am
8-K
0kjuzigqcedcn51t6pr8
13 Apr 15
Departure of Directors or Certain Officers
12:00am
8-K
duzecfi84pl
3 Apr 15
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
spza6yxw3g ugm
1 Apr 15
Columbia Laboratories Acquires Exclusive Worldwide License to a Novel
12:00am
8-K
i0xjncx gl
18 Mar 15
Columbia Laboratories Reports Fourth Quarter and Full-Year 2014 Financial Results
12:00am